Saulzet, France

Jérôme Busserolles

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2015-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Jérôme Busserolles

Introduction

Jérôme Busserolles is a notable inventor based in Saulzet, France. He has made significant contributions to the field of pain relief and cancer treatment through his innovative patents. With a total of 3 patents, his work has the potential to impact the medical community positively.

Latest Patents

One of his latest patents focuses on pain relief compounds. This invention relates to the use of compounds for the treatment or prevention of pain in mammals, particularly in human beings. It also includes a process for preparing these compounds. Another significant patent involves the use of riluzole for treating or preventing the adverse effects of antineoplastic agents. This invention addresses the neurotoxic effects associated with anticancer agents, such as platinum salts, taxanes, and periwinkle alkaloids.

Career Highlights

Throughout his career, Jérôme has worked with esteemed institutions such as the École Nationale Supérieure de Chimie de Clermont-Ferrand and the Université Clermont Auvergne. His work in these organizations has allowed him to develop and refine his innovative ideas.

Collaborations

Jérôme has collaborated with notable individuals in his field, including Alain Eschalier and Sylvie Ducki. These partnerships have contributed to the advancement of his research and inventions.

Conclusion

Jérôme Busserolles exemplifies the spirit of innovation in the medical field. His patents in pain relief and cancer treatment showcase his dedication to improving human health. His contributions are a testament to the importance of research and collaboration in driving advancements in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…